95 related articles for article (PubMed ID: 3177518)
1. Endocrine aspects of human uterine sarcoma.
Quinn MA
Am J Obstet Gynecol; 1988 Oct; 159(4):1019. PubMed ID: 3177518
[No Abstract] [Full Text] [Related]
2. [Current status of drug treatment of endometrial carcinoma].
Schulz KD; Kaiser R
Gynakologe; 1983 Jun; 16(2):114-8. PubMed ID: 6193040
[No Abstract] [Full Text] [Related]
3. Uterine myeloid sarcoma.
Martino G; Zanelli M; Zizzo M; Quintini M; Ricci L; Marra A; Ascani S
Ann Hematol; 2020 Jul; 99(7):1671-1672. PubMed ID: 32367177
[No Abstract] [Full Text] [Related]
4. [Polychemotherapy in the treatment of genital sarcomata (author's transl)].
Ptácková B; Kucera F
Cesk Gynekol; 1976 Dec; 41(10):739-40. PubMed ID: 1009610
[No Abstract] [Full Text] [Related]
5. Endocrine aspects of human uterine sarcoma: a preliminary study.
Tseng L; Tseng JK; Mann WJ; Chumas JC; Stone ML; Mazella J; Sun B; Amalfitano TG; Wallach RC
Am J Obstet Gynecol; 1986 Jul; 155(1):95-101. PubMed ID: 2942037
[TBL] [Abstract][Full Text] [Related]
6. [Views concerning uterine and ovarian sarcomas].
Scarabelli C; Berta V; Confalonieri F; Guarneri A; Marcolli G
Chir Ital; 1978 Dec; 30(6):913-8. PubMed ID: 753547
[No Abstract] [Full Text] [Related]
7. [Chemotherapy and hormone therapy for uterine sarcomas].
Yamashita H; Arai H; Aoki D
Gan To Kagaku Ryoho; 2012 May; 39(5):722-5. PubMed ID: 22584323
[TBL] [Abstract][Full Text] [Related]
8. Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas.
Hensley ML
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):773-82. PubMed ID: 21752717
[TBL] [Abstract][Full Text] [Related]
9. Systemic chemotherapy for uterine carcinoma: metastatic and adjuvant.
Fleming GF
J Clin Oncol; 2007 Jul; 25(20):2983-90. PubMed ID: 17617530
[No Abstract] [Full Text] [Related]
10. Aminoglutethimide and warfarin. A new important drug interaction.
Lønning PE; Kvinnsland S; Jahren G
Cancer Chemother Pharmacol; 1984; 12(1):10-2. PubMed ID: 6690067
[TBL] [Abstract][Full Text] [Related]
11. [Podophyllin derivatives in chemotherapy of malignant tumors].
Limburg H
Planta Med; 1972 Nov; 22(3):348-57. PubMed ID: 4649590
[No Abstract] [Full Text] [Related]
12. Steroid receptors in endolymphatic stromal myosis.
Baker VV; Walton LA; Fowler WC; Currie JL
Obstet Gynecol; 1984 Mar; 63(3 Suppl):72S-74S. PubMed ID: 6700885
[TBL] [Abstract][Full Text] [Related]
13. Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma.
Santen RJ; Santner S; Davis B; Veldhuis J; Samojlik E; Ruby E
J Clin Endocrinol Metab; 1978 Dec; 47(6):1257-65. PubMed ID: 263348
[No Abstract] [Full Text] [Related]
14. Aminoglutethimide--a new endocrine therapy in breast cancer. A cancer research review.
Harris AL
Exp Cell Biol; 1985; 53(1):1-8. PubMed ID: 3881300
[TBL] [Abstract][Full Text] [Related]
15. Further report on therapeutic effect of abrin and ricin on human cancers.
Hsu CT; Lin JY; Tung TC
Taiwan Yi Xue Hui Za Zhi; 1974 Sep; 73(9):526-42. PubMed ID: 4530824
[No Abstract] [Full Text] [Related]
16. Inhibition of P-glycoprotein-mediated transport by S-adenosylmethionine and cynarin in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells.
Angelini A; Di Pietro R; Centurione L; Castellani ML; Conti P; Porreca E; Cuccurullo F
J Biol Regul Homeost Agents; 2012; 26(3):495-504. PubMed ID: 23034269
[TBL] [Abstract][Full Text] [Related]
17. Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles.
Ioffe YJ; Li AJ; Walsh CS; Karlan BY; Leuchter R; Forscher C; Cass I
Gynecol Oncol; 2009 Dec; 115(3):466-71. PubMed ID: 19767065
[TBL] [Abstract][Full Text] [Related]
18. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
[TBL] [Abstract][Full Text] [Related]
19. ABCB1, ABCC1, and LRP gene expressions are altered by LDL, HDL, and serum deprivation in a human doxorubicin-resistant uterine sarcoma cell line.
Celestino AT; Levy D; Maria Ruiz JL; Bydlowski SP
Biochem Biophys Res Commun; 2015 Feb; 457(4):664-8. PubMed ID: 25603048
[TBL] [Abstract][Full Text] [Related]
20. The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell lines.
Coley HM; Shotton CF; Kokkinos MI; Thomas H
Gynecol Oncol; 2007 May; 105(2):462-9. PubMed ID: 17300833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
